Ross McKinnon

Ross McKinnon

Flinders University

H-index: 48

Oceania-Australia

About Ross McKinnon

Ross McKinnon, With an exceptional h-index of 48 and a recent h-index of 30 (since 2020), a distinguished researcher at Flinders University, specializes in the field of pharmacology, pharmacy, cancer, drug metabolism.

His recent articles reflect a diverse array of research interests and contributions to the field:

Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation

A Comprehensive Bioinformatic Analysis of RNA-seq Datasets Reveals a Differential and Variable Expression of Wildtype and Variant UGT1A Transcripts in Human Tissues and Their …

Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials

Activation of Cryptic Donor Splice Sites Within the UGT1A First-Exon Region Generates Variant Transcripts That Encode UGT1A Proteins With Truncated Aglycone-binding Domains

A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials

Special Paper: Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional …

Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis

Heterogeneity and utility of pharmaceutical company sharing of individual-participant data packages

Ross McKinnon Information

University

Position

___

Citations(all)

9077

Citations(since 2020)

3703

Cited By

6676

hIndex(all)

48

hIndex(since 2020)

30

i10Index(all)

151

i10Index(since 2020)

89

Email

University Profile Page

Flinders University

Google Scholar

View Google Scholar Profile

Ross McKinnon Skills & Research Interests

pharmacology

pharmacy

cancer

drug metabolism

Top articles of Ross McKinnon

Title

Journal

Author(s)

Publication Date

Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation

Journal of Clinical Epidemiology

Ashley M Hopkins

Natansh D Modi

Frank W Rockhold

Tammy Hoffmann

Bradley D Menz

...

2024/3/1

A Comprehensive Bioinformatic Analysis of RNA-seq Datasets Reveals a Differential and Variable Expression of Wildtype and Variant UGT1A Transcripts in Human Tissues and Their …

Cancers

Dong Gui Hu

Shashikanth Marri

Julie-Ann Hulin

Ross A McKinnon

Peter I Mackenzie

...

2024/1/13

Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials

Scientific Reports

Sara A Almansour

Mohammad AY Alqudah

Ziad Abuhelwa

Humaid O Al-Shamsi

Mohammad H Semreen

...

2024/1/5

Activation of Cryptic Donor Splice Sites Within the UGT1A First-Exon Region Generates Variant Transcripts That Encode UGT1A Proteins With Truncated Aglycone-binding Domains

Drug Metabolism and Disposition

Dong Gui Hu

Shashikanth Marri

Julie-Ann Hulin

Radwan Ansaar

Peter I Mackenzie

...

2024/1/1

A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials

BMC cancer

Lee X Li

Mark A Socinski

Ganessan Kichenadasse

Christos S Karapetis

Adel Shahnam

...

2024/3/25

Special Paper: Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional …

The BMJ

Bradley D Menz

Nicole M Kuderer

Stephen Bacchi

Natansh D Modi

Benjamin Chin-Yee

...

2024

Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis

bmj

Bradley D Menz

Nicole M Kuderer

Stephen Bacchi

Natansh D Modi

Benjamin Chin-Yee

...

2024/3/20

Heterogeneity and utility of pharmaceutical company sharing of individual-participant data packages

JAMA oncology

Ashley M Hopkins

Natansh D Modi

Ahmad Y Abuhelwa

Ganessan Kichenadasse

Nicole M Kuderer

...

2023/12/1

A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies

BMC medicine

Natansh D Modi

Ganessan Kichenadasse

Tammy C Hoffmann

Mark Haseloff

Jessica M Logan

...

2023/10/23

The molecular basis of dapsone activation of CYP2C9-catalyzed non-steroidal anti-inflammatory drug (NSAID) oxidation

Journal of Biological Chemistry

Pramod C Nair

Kushari Burns

Nuy Chau

Ross A McKinnon

John O Miners

2023/10/20

Association between patient-reported outcomes and therapeutic outcomes in patients with breast cancer: A pooled individual-participant data analysis.

Natansh Modi

Ahmad Y Abuhelwa

Andrew Rowland

Bradley D Menz

Ross Allan McKinnon

...

2023/6/1

Transforming pharmaceutical education: A needs-based global analysis for policy development

Exploratory Research in Clinical and Social Pharmacy

Alison Etukakpan

Nilhan Uzman

Ozge Ozer

Toyin Tofade

Silvana Nair Leite

...

2023/3/1

Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150

British Journal of Cancer

Ashley M Hopkins

Ganessan Kichenadasse

Ross A McKinnon

Ahmad Y Abuhelwa

Jessica M Logan

...

2022/1/1

Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer

ESMO open

ND Modi

NO Danell

RNA Perry

AY Abuhelwa

A Rathod

...

2022/6/1

Marine bioactives: from energy to nutrition

Munish Puri

Adarsha Gupta

Ross A McKinnon

Reinu E Abraham

2022/3/1

The Somatic Mutation Landscape of UDP-Glycosyltransferase (UGT) Genes in Human Cancers

Cancers

Dong Gui Hu

Shashikanth Marri

Julie-Ann Hulin

Ross A McKinnon

Peter I Mackenzie

...

2022/11/21

Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugs

Pramod C Nair

John O Miners

Ross A McKinnon

Christopher J Langmead

Karen J Gregory

...

2022/1

A functional screen with metformin identifies microRNAs that regulate metabolism in colorectal cancer cells

Scientific Reports

Ayla Orang

Saira R Ali

Janni Petersen

Ross A McKinnon

Amanda L Aloia

...

2022/2/21

Chemical similarities and differences among inhibitors of nitric oxide synthase, arginase and dimethylarginine dimethylaminohydrolase-1: Implications for the design of novel …

Anthony J Doman

Sara Tommasi

Michael V Perkins

Ross A McKinnon

Arduino A Mangoni

...

2022/10/15

Efficacy of atezolizumab in patients with advanced NSCLC receiving concomitant antibiotic or proton pump inhibitor treatment: pooled analysis of five randomized control trials

Journal of Thoracic Oncology

Ashley M Hopkins

Sarah Badaoui

Ganessan Kichenadasse

Christos S Karapetis

Ross A McKinnon

...

2022/6/1

See List of Professors in Ross McKinnon University(Flinders University)

Co-Authors

H-index: 136
Daniel W Nebert

Daniel W Nebert

University of Cincinnati

H-index: 74
Peter Ian Mackenzie

Peter Ian Mackenzie

Flinders University

H-index: 60
Winkler, D*

Winkler, D*

La Trobe University

H-index: 56
Sanford L. Boye

Sanford L. Boye

University of Florida

H-index: 40
Michael Sorich

Michael Sorich

Flinders University

H-index: 34
Andrew Rowland

Andrew Rowland

Flinders University

academic-engine